Literature DB >> 17467261

Deconstructing common variable immunodeficiency by genetic analysis.

Alejandro A Schäffer1, Ulrich Salzer, Lennart Hammarström, Bodo Grimbacher.   

Abstract

Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency. Patients have recurrent bacterial infections and an increased risk of developing autoimmune diseases, lung damage, and selected cancers. Since 2003, four genes have been shown to be mutated in CVID patients: ICOS, TNFRSF13B (encoding TACI), TNFRSF13C (encoding BAFF-R) and CD19. Heterozygous mutations in TNFRSF13B are also associated with CVID, whereas the other three genes are purely recessive. Recent genetic linkage studies have also identified possible loci for dominant CVID genes on chromosomes 4q, 5p and 16q. These findings markedly improved the genetic diagnosis of CVID and point towards new strategies for future genetic studies. In addition, some CVID genes might be relevant to more common diseases such as asthma and stroke.

Entities:  

Mesh:

Year:  2007        PMID: 17467261     DOI: 10.1016/j.gde.2007.04.002

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  18 in total

1.  Role of B cells in common variable immune deficiency.

Authors:  Sam Ahn; Charlotte Cunningham-Rundles
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

2.  A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID).

Authors:  Kaushang Gandhi; Purvi Parikh; Wilbert S Aronow; Harit Desai; Harshad Amin; Mala Sharma; Arye Rubinstein
Journal:  J Gastrointest Cancer       Date:  2010-12

3.  Common variable immunodeficiency in horses is characterized by B cell depletion in primary and secondary lymphoid tissues.

Authors:  M Julia B F Flaminio; Rebecca L Tallmadge; Cristina O M Salles-Gomes; Mary Beth Matychak
Journal:  J Clin Immunol       Date:  2008-08-02       Impact factor: 8.317

4.  TACI mutations and disease susceptibility in patients with common variable immunodeficiency.

Authors:  A E J Poodt; G J A Driessen; A de Klein; J J M van Dongen; M van der Burg; E de Vries
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

Review 5.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

Review 6.  Therapeutic management of primary immunodeficiency in older patients.

Authors:  Nisha Verma; Anthony Thaventhiran; Benjamin Gathmann; James Thaventhiran; Bodo Grimbacher
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

7.  Homologous recombination is necessary for normal lymphocyte development.

Authors:  Lura B Caddle; Muneer G Hasham; William H Schott; Bobbi-Jo Shirley; Kevin D Mills
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

Review 8.  Autoimmunity in common variable immunodeficiency.

Authors:  Susana Lopes-da-Silva; Luiz Vicente Rizzo
Journal:  J Clin Immunol       Date:  2008-04-29       Impact factor: 8.317

Review 9.  Autoimmunity in common variable immunodeficiency.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

Review 10.  Diagnostic Tools for Inborn Errors of Human Immunity (Primary Immunodeficiencies and Immune Dysregulatory Diseases).

Authors:  Annely M Richardson; Ann M Moyer; Linda Hasadsri; Roshini S Abraham
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-22       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.